United States · Investor

Burrill & Company

Last cheque observed Apr 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmWebsite unconfirmed

Series BVentureSeries ABiotechnologyInternetMedical Device

Cheques on record
0%of best year0cheques in 12 months, 65 on record
Since the last cheque4575days00hrs00min00sec
Median round$15MRounds led0 of 65Sole investor1 roundsExits6 from the portfolioMostly inUnited States, 98%
Pitch Burrill & Company

Burrill & Company highlights

  1. 01

    65 rounds on record

  2. 02

    Mostly Series B and Venture: 52% of its rounds

  3. 03

    Sole investor in 1 rounds, median $13M

  4. 04

    6 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyInternetMedical Device
Based in
San Francisco, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first65 appearances

  1. 2014

    2 rounds

  2. Apr
    Nora TherapeuticsSeries B · US$18MWith 4 others
  3. Mar
    Neos TherapeuticsSeries C · US$16MWith 3 others
  4. 2013

    3 rounds

  5. Oct
    BetterDoctorSeed · US · techcrunch.com$2.6MWith 7 others
  6. Apr
    Catalyst BiosciencesVenture · US$5.1MWith 5 others
  7. Feb
    Odyssey TheraVenture · US · pevc.dowjones.com$2.8MWith 2 others
  8. 2012

    9 rounds

  9. Nov
    MabVax TherapeuticsSeries B · US · finsmes.com$5.3MWith 1 other
  10. Oct
    Cobalt TechnologiesVenture · US$5.0MWith 2 others
  11. Sept
    Catalyst BiosciencesVenture · US · sec.gov$13MWith 4 others
  12. Jun
    AliveCorSeries B · US · in.finance.yahoo.com$11MWith 3 others
  13. Jun
    Ceptaris TherapeuticsSeries D · US · finsmes.com$10MWith 5 others
  14. Apr
    WhiteGlove HealthSeries E · US · whiteglove.com$13MSole investor
  15. Apr
    WaveTec VisionVenture · US · pevc.dowjones.com$17MWith 2 others
  16. Apr
    Cobalt TechnologiesVenture · US$2.9MWith 4 others
  17. Mar
    VirdiaVenture · US · virdia.com$20MWith 2 others
  18. 2011

    2 rounds

  19. Aug
    Yaupon TherapeuticsSeries D · US · finsmes.com$14MWith 3 others
  20. Aug
    AliveCorSeries A · US · techcrunch.com$3.0MWith 2 others
  21. 2010

    3 rounds

  22. Sept
    NewBridge PharmaceuticalsSeries B · AE · finsmes.com$12MWith 1 other
  23. Jun
    FerroKin BiosciencesSeries B · US · fiercebiotech.com$12MWith 4 others
  24. Jan
    EndocyteSeries C · US · onbiovc.com$26MWith 4 others
  25. 2009

    6 rounds

  26. Oct
    PrimeraDx (Primera Biosystems)Series C · US · onbiovc.com$20MWith 5 others
  27. Oct
    CareDxVenture · US · onbiovc.com$14MWith 6 others
  28. Aug
    GevoVenture · US$40MWith 6 others
  29. Aug
    CareDxSeries F · US · sanjose.bizjournals.com$14MWith 7 others
  30. Jun
    VirdiaSeries A · US · earth2tech.com$5.5MWith 1 other
  31. Apr
    AerovanceVenture · US · venturebeat.com$38MWith 7 others
  32. 2008

    7 rounds

  33. Dec
    Catalyst BiosciencesSeries C · US · fiercebiotech.com$40MWith 6 others
  34. Sept
    Osprey Pharmaceuticals USASeries A · US · ospreypharma.com$11MWith 5 others
  35. Aug
    BioImageneSeries D · US$26MWith 4 others
  36. Aug
    WellpartnerSeries D · US$16MWith 5 others
  37. May
    GevoSeries C · US · deals.venturebeat.com$17MWith 3 others
  38. Mar
    NanoVascSeries A · US · venturebeatprofiles.com$4.7MWith 1 other
  39. Jan
    PrimeraDx (Primera Biosystems)Series B · US$12MWith 5 others
  40. 2007

    10 rounds

  41. Sept
    ChlorogenVenture · US$15MWith 4 others
  42. Jul
    Light Sciences OncologySeries B · US · venturebeat.com$30MWith 4 others
  43. Jun
    Logical TherapeuticsSeries B · US$30MWith 4 others
  44. Jun
    PhytomedicsSeries B · US$9.0MWith 1 other
  45. Jun
    Dreamerz FoodsSeries B · US · deals.venturebeat.com$10MWith 6 others
  46. May
    Arete TherapeuticsSeries A · US$35MWith 4 others
  47. Mar
    AerovanceSeries C · US · deals.venturebeat.com$60MWith 5 others
  48. Mar
    EndocyteSeries C · US$15MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

WaveTec VisionBought by AlconUndisclosedSept 2014
VirdiaBought by Stora Enso$33MJun 2014
Ceptaris TherapeuticsBought by Actelion Pharmaceuticals$250MJul 2013
CardiokineBought by Cornerstone TherapeuticsUndisclosedJan 2012
BioImageneBought by Roche$100MAug 2010
Corus PharmaBought by Gilead SciencesUndisclosedOct 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Burrill & Company. A count of rooms they were both in, not a relationship either has claimed.

Prolog VenturesVC firm6rounds togetherKhosla VenturesVC firm5rounds togetherMorgenthaler VenturesVC firm5rounds togetherGreat Spirit VenturesGrowth equity4rounds togetherHealthCare VenturesGrowth equity4rounds togetherIntegral Capital PartnersGrowth equity4rounds togetherJohnson & Johnson Development Corporation (JJDC)VC firm4rounds togetherKleiner Perkins Caufield & ByersVC firm4rounds togetherNovo Holdings A/SGrowth equity4rounds togetherAlta PartnersVC firm3rounds togetherApax PartnersPrivate equity3rounds togetherBlue Chip Venture CompanyVC firm3rounds together

Quick answers about Burrill & Company

What does Burrill & Company invest in?

Burrill & Company invests most often at Series B and Venture (52% of the rounds on record), in sectors such as Biotechnology, Internet and Medical Device.

How active is Burrill & Company?

65 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2014.

How big are Burrill & Company's cheques?

The median round it joins is $15M.

Does Burrill & Company lead rounds?

Rarely, if at all: none of its 65 investments on record names it as the lead.

Where does Burrill & Company invest?

Most of the companies it backs are in the United States (98%).

Is Burrill & Company investing now?

No investments in the last 12 months; the latest was in Apr 2014.

Who does Burrill & Company invest alongside?

Most often Prolog Ventures (6 rounds together), Khosla Ventures (5 rounds together) and Morgenthaler Ventures (5 rounds together).

What kind of investor is Burrill & Company?

Burrill & Company is a VC firm based in San Francisco, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it